Risk of Progressive Multifocal Leukoencephalopathy in the Combination Antiretroviral Therapy Era in the French Hospital Database on Human Immunodeficiency Virus (ANRS-C4)
Author(s) -
Hugues Melliez,
Murielle MaryKrause,
Laurence Bocket,
Marguerite Guiguet,
Sophie Abgrall,
Pierre de Truchis,
Christine Katlama,
Guillaume MartinBlondel,
Aurélia Henn,
Matthieu Revest,
Olivier Robineau,
Marie-Aude Khuong-Josses,
Anna Canestri,
Nathalie De Castro,
Véronique Joly,
Saadia Mokhtari,
Karine Risso,
Jacques Gasnault,
Dominique Costagliola
Publication year - 2018
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciy074
Subject(s) - medicine , progressive multifocal leukoencephalopathy , hazard ratio , cart , incidence (geometry) , cohort , confidence interval , cohort study , pediatrics , immunology , virology , virus , mechanical engineering , physics , optics , engineering
Risk factors for progressive multifocal leukoencephalopathy (PML) in individuals with human immunodeficiency virus (HIV) infection are poorly documented in the era of combination antiretroviral therapy (cART).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom